Grant received in 2022
DCCC has funded 80,200 DKK to the project
The application is for a workshop designed to define the treatment strategy, workflow, as well as initiation of the actual protocol writing. Standard treatment of de novo oligometastatic breast cancer is, as yet, undefined, with no national nor international guidelines.
Consequently, a multi-disciplinary approach is necessary, and it is important to achieve agreement on treatment strategy with participation from the surgical, medical oncology, radiotherapy, and diagnostic specialties.
The agreed upon treatment and follow-up strategy will form the basis of the design of DBCG CLEVERER.
Multidisciplinary organisation
DBCG - Danish Breast Cancer Cooperative Group
Project stakeholder
- Professor, Chief Physician, PhD, Birgitte Offersen, Aarhus University Hospital (chair of the DBCG and radiotherapy committee)
- Maja Vestmø Maraldo, PhD, department doctor. Primary contact, e-mail: maja.vestmoe.maraldo@regionh.dk
- Physicist Esben Yates, Aarhus University Hospital Physicist Kristian Boye, Rigshospitalet
- Departmental doctor Else Maae, Vejle Hospital
- Physicist Martin Berg, Vejle Hospital
- Chief physician, PhD, Louise Wichmann Matthiessen, Herlev and Gentofte hospital
- Physicist Karen Andersen, Herlev and Gentofte hospital
- Chief physician Sami Al-Rawi, Næstved Hospital
- Physicist Kirsten Legaard Jakobsen, Næstved Hospital
- Chief Physician, PhD, Mette H. Nielsen, Odense University
- Hospital Physicist, PhD, Ebbe Lorenzen, Odense University Hospital
- Ward doctor Mette Møller, Aalborg University Hospital
- Physicist Ingelise Jensen, Aalborg University Hospital
- Chief Physician, PhD, Ann Knop, Rigshospitalet (Chairman of the Medical Committee of DBCG)
- Chief Physician, MD, PhD, Tove Filtenborg Tvedskov, Herlev and Gentofte Hospital (chairman of the surgical committee in DBCG)
- Chief Physician, Ilse Vejborg, Herlev and Gentofte Hospital (chairman of the imaging committee in DBCG)